Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction
Status:
Completed
Trial end date:
2018-01-19
Target enrollment:
Participant gender:
Summary
The objective of the study is to compare the pharmacokinetics profiles and safety of
Evogliptin in patients wit hepatic dysfunction versus healthy volunteers after single oral
dose of Evogliptin